Concepts (155)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Anti-Asthmatic Agents | 6 | 2019 | 427 | 1.92 | Why? |
| Asthma | 21 | 2021 | 4383 | 1.88 | Why? |
| Omalizumab | 3 | 2019 | 158 | 1.28 | Why? |
| Lipid A | 1 | 2019 | 32 | 0.80 | Why? |
| Pulmonary Eosinophilia | 1 | 2019 | 46 | 0.80 | Why? |
| Anaphylaxis | 5 | 2021 | 940 | 0.77 | Why? |
| Nasal Polyps | 3 | 2019 | 221 | 0.70 | Why? |
| Rhinitis, Allergic, Seasonal | 1 | 2019 | 121 | 0.69 | Why? |
| Eosinophilia | 2 | 2019 | 292 | 0.64 | Why? |
| Cell Adhesion Molecules | 1 | 2017 | 472 | 0.55 | Why? |
| Forced Expiratory Volume | 3 | 2019 | 632 | 0.45 | Why? |
| Antibodies, Monoclonal, Humanized | 4 | 2019 | 9335 | 0.42 | Why? |
| Mediastinal Emphysema | 1 | 2017 | 519 | 0.41 | Why? |
| Hypersensitivity | 2 | 2021 | 1137 | 0.39 | Why? |
| Drug Substitution | 2 | 2019 | 385 | 0.30 | Why? |
| Eosinophils | 3 | 2019 | 848 | 0.27 | Why? |
| Allergens | 4 | 2018 | 728 | 0.25 | Why? |
| Patient Selection | 1 | 2017 | 4560 | 0.24 | Why? |
| Desensitization, Immunologic | 3 | 2019 | 574 | 0.24 | Why? |
| Adrenergic beta-Agonists | 1 | 2019 | 93 | 0.19 | Why? |
| Patient Dropouts | 1 | 2018 | 96 | 0.18 | Why? |
| Status Asthmaticus | 1 | 2017 | 12 | 0.18 | Why? |
| Alternariosis | 1 | 2017 | 14 | 0.18 | Why? |
| Sulfides | 1 | 2019 | 113 | 0.18 | Why? |
| Churg-Strauss Syndrome | 1 | 2018 | 61 | 0.18 | Why? |
| Acetates | 1 | 2019 | 123 | 0.17 | Why? |
| Anti-Allergic Agents | 1 | 2019 | 167 | 0.17 | Why? |
| Cyclopropanes | 1 | 2019 | 332 | 0.16 | Why? |
| Prostate-Specific Antigen | 1 | 2017 | 213 | 0.16 | Why? |
| Wheat Hypersensitivity | 1 | 2015 | 13 | 0.16 | Why? |
| Hypersensitivity, Immediate | 1 | 2017 | 134 | 0.15 | Why? |
| Granulomatosis with Polyangiitis | 1 | 2018 | 161 | 0.15 | Why? |
| Exhalation | 1 | 2019 | 441 | 0.15 | Why? |
| Triticum | 1 | 2015 | 54 | 0.15 | Why? |
| Glutens | 1 | 2015 | 55 | 0.15 | Why? |
| Respiratory Function Tests | 2 | 2019 | 1755 | 0.14 | Why? |
| Quinolines | 1 | 2019 | 403 | 0.14 | Why? |
| Breath Tests | 1 | 2017 | 338 | 0.13 | Why? |
| Semen | 1 | 2017 | 550 | 0.11 | Why? |
| Food Hypersensitivity | 1 | 2017 | 397 | 0.11 | Why? |
| Rhinitis, Allergic | 1 | 2019 | 704 | 0.11 | Why? |
| Community Pharmacy Services | 1 | 2017 | 426 | 0.11 | Why? |
| Urticaria | 1 | 2017 | 472 | 0.11 | Why? |
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2020 | 1454 | 0.10 | Why? |
| Nitric Oxide | 1 | 2017 | 769 | 0.10 | Why? |
| Patient Preference | 1 | 2017 | 750 | 0.10 | Why? |
| Psychometrics | 1 | 2017 | 1269 | 0.10 | Why? |
| BCG Vaccine | 1 | 2020 | 1137 | 0.10 | Why? |
| Immunoglobulin E | 3 | 2018 | 557 | 0.10 | Why? |
| Menstrual Cycle | 1 | 1989 | 59 | 0.10 | Why? |
| Adjuvants, Immunologic | 1 | 2019 | 1709 | 0.10 | Why? |
| Adult | 17 | 2020 | 244371 | 0.09 | Why? |
| Recurrence | 1 | 2019 | 3675 | 0.09 | Why? |
| Rhinitis | 3 | 2018 | 626 | 0.09 | Why? |
| Adolescent | 8 | 2020 | 86841 | 0.09 | Why? |
| Heart | 1 | 2018 | 1791 | 0.09 | Why? |
| Young Adult | 8 | 2019 | 93724 | 0.09 | Why? |
| Sexual Behavior | 1 | 2017 | 1322 | 0.09 | Why? |
| Middle Aged | 16 | 2020 | 270681 | 0.09 | Why? |
| Cost of Illness | 1 | 2018 | 1903 | 0.09 | Why? |
| Italy | 7 | 2020 | 38444 | 0.08 | Why? |
| Severity of Illness Index | 7 | 2020 | 48226 | 0.08 | Why? |
| Smoking | 2 | 2017 | 3358 | 0.08 | Why? |
| Child, Preschool | 3 | 2020 | 36283 | 0.08 | Why? |
| Treatment Outcome | 5 | 2020 | 51732 | 0.08 | Why? |
| Humans | 30 | 2021 | 930598 | 0.08 | Why? |
| Oxygen Inhalation Therapy | 1 | 2020 | 3629 | 0.08 | Why? |
| Gonadal Steroid Hormones | 1 | 1989 | 328 | 0.08 | Why? |
| Male | 17 | 2021 | 367725 | 0.08 | Why? |
| Biological Products | 1 | 2020 | 2331 | 0.07 | Why? |
| Chloroquine | 1 | 2020 | 3152 | 0.07 | Why? |
| Prevalence | 5 | 2020 | 25773 | 0.07 | Why? |
| Hypoxia | 1 | 2020 | 3626 | 0.07 | Why? |
| Drug Therapy, Combination | 1 | 2019 | 7268 | 0.07 | Why? |
| Female | 18 | 2021 | 380317 | 0.07 | Why? |
| Inpatients | 1 | 2020 | 5161 | 0.07 | Why? |
| Oxygen | 1 | 2017 | 3715 | 0.07 | Why? |
| Aged | 12 | 2020 | 215776 | 0.06 | Why? |
| Prospective Studies | 2 | 2019 | 43301 | 0.06 | Why? |
| Socioeconomic Factors | 2 | 2018 | 8495 | 0.06 | Why? |
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2020 | 5277 | 0.06 | Why? |
| Ipratropium | 1 | 2001 | 16 | 0.06 | Why? |
| Skiing | 1 | 2001 | 19 | 0.06 | Why? |
| Betacoronavirus | 3 | 2020 | 204454 | 0.06 | Why? |
| Child | 3 | 2020 | 70012 | 0.06 | Why? |
| Adrenal Cortex Hormones | 1 | 2019 | 6537 | 0.06 | Why? |
| Cholinergic Antagonists | 1 | 2001 | 56 | 0.06 | Why? |
| Radiography, Thoracic | 1 | 2017 | 5486 | 0.05 | Why? |
| Pulmonary Disease, Chronic Obstructive | 1 | 2018 | 3832 | 0.05 | Why? |
| Sex Factors | 1 | 2017 | 11014 | 0.05 | Why? |
| Length of Stay | 1 | 2017 | 11042 | 0.05 | Why? |
| Respiratory Insufficiency | 1 | 2020 | 7301 | 0.05 | Why? |
| Pregnancy Complications | 1 | 1989 | 1388 | 0.04 | Why? |
| Pollen | 1 | 2018 | 137 | 0.04 | Why? |
| Pneumonia, Viral | 3 | 2020 | 243684 | 0.04 | Why? |
| Inflammation | 1 | 2020 | 13255 | 0.04 | Why? |
| Coronavirus Infections | 3 | 2020 | 253789 | 0.04 | Why? |
| Risk Factors | 4 | 2020 | 71621 | 0.04 | Why? |
| Polyethylene Glycols | 1 | 2021 | 574 | 0.04 | Why? |
| Adverse Drug Reaction Reporting Systems | 1 | 2021 | 694 | 0.04 | Why? |
| Chromosomes, Plant | 1 | 2015 | 19 | 0.04 | Why? |
| Flour | 1 | 2015 | 17 | 0.04 | Why? |
| Gliadin | 1 | 2015 | 26 | 0.04 | Why? |
| Age Factors | 1 | 2017 | 21039 | 0.04 | Why? |
| Biomarkers | 1 | 2019 | 23361 | 0.04 | Why? |
| Molecular Mimicry | 1 | 2017 | 190 | 0.04 | Why? |
| Antigens, Plant | 1 | 2015 | 40 | 0.04 | Why? |
| Exercise | 1 | 2015 | 6771 | 0.04 | Why? |
| Cannula | 1 | 2020 | 750 | 0.03 | Why? |
| Cyclonic Storms | 1 | 2018 | 236 | 0.03 | Why? |
| Skin Tests | 1 | 2015 | 229 | 0.03 | Why? |
| Bronchiectasis | 1 | 2018 | 312 | 0.03 | Why? |
| Surveys and Questionnaires | 2 | 2020 | 43792 | 0.03 | Why? |
| Sex Characteristics | 1 | 2021 | 1120 | 0.03 | Why? |
| Quarantine | 1 | 2020 | 18418 | 0.03 | Why? |
| Treatment Failure | 1 | 2019 | 2106 | 0.03 | Why? |
| Sinusitis | 1 | 2000 | 649 | 0.03 | Why? |
| Injections, Subcutaneous | 1 | 2014 | 647 | 0.03 | Why? |
| Cross-Sectional Studies | 4 | 2020 | 53120 | 0.03 | Why? |
| Tomography, X-Ray Computed | 1 | 2017 | 25144 | 0.03 | Why? |
| Comorbidity | 3 | 2020 | 34796 | 0.03 | Why? |
| Dogs | 1 | 2017 | 2529 | 0.03 | Why? |
| Lung | 1 | 2017 | 31049 | 0.02 | Why? |
| Aged, 80 and over | 4 | 2020 | 88759 | 0.02 | Why? |
| Menopause | 1 | 1989 | 136 | 0.02 | Why? |
| Health Care Surveys | 1 | 2017 | 2942 | 0.02 | Why? |
| Noninvasive Ventilation | 1 | 2020 | 2329 | 0.02 | Why? |
| Environmental Exposure | 1 | 2017 | 1558 | 0.02 | Why? |
| Quality of Life | 2 | 2017 | 9820 | 0.02 | Why? |
| Employment | 1 | 2017 | 1754 | 0.02 | Why? |
| Cross Reactions | 1 | 2017 | 4374 | 0.02 | Why? |
| Perception | 1 | 2017 | 2827 | 0.02 | Why? |
| Pandemics | 4 | 2020 | 389249 | 0.02 | Why? |
| Plant Extracts | 1 | 2015 | 1514 | 0.02 | Why? |
| Health Status | 1 | 2017 | 3259 | 0.02 | Why? |
| Databases, Factual | 1 | 2018 | 6248 | 0.02 | Why? |
| Diagnosis, Differential | 1 | 2018 | 7220 | 0.02 | Why? |
| Epitopes | 1 | 2015 | 4113 | 0.02 | Why? |
| Chronic Disease | 1 | 2017 | 5139 | 0.02 | Why? |
| Rhinitis, Allergic, Perennial | 1 | 2000 | 36 | 0.01 | Why? |
| Reproducibility of Results | 1 | 2017 | 11304 | 0.01 | Why? |
| Cold Temperature | 1 | 2001 | 260 | 0.01 | Why? |
| Animals | 2 | 2021 | 78931 | 0.01 | Why? |
| Enzyme-Linked Immunosorbent Assay | 1 | 2015 | 7868 | 0.01 | Why? |
| Diabetes Mellitus, Type 2 | 1 | 2020 | 6166 | 0.01 | Why? |
| Registries | 1 | 2018 | 12327 | 0.01 | Why? |
| Cross-Over Studies | 1 | 2001 | 867 | 0.01 | Why? |
| Retrospective Studies | 2 | 2020 | 105322 | 0.01 | Why? |
| Critical Care | 1 | 2020 | 14081 | 0.01 | Why? |
| Cohort Studies | 1 | 2020 | 36005 | 0.01 | Why? |
| Respiration, Artificial | 1 | 2020 | 22116 | 0.01 | Why? |
| Vaccination | 1 | 2020 | 19050 | 0.01 | Why? |
| Double-Blind Method | 1 | 2001 | 5988 | 0.01 | Why? |
| Hospitalization | 1 | 2020 | 54280 | 0.01 | Why? |
| Pregnancy | 1 | 1989 | 23879 | 0.01 | Why? |
Senna's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(155)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(109)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_